HealthcareNSE · BSE

Emcure Pharmaceuticals Limited

EMCURE · ISIN INE168P01015

Share price

₹1,734▲ +1.66%

Market capitalisation

₹32885 Cr● Closed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹32885 Cr

Current price

₹1,734

+1.66% today

52W high

₹1,830

52W low

₹1,229

Stock P/E

35.55

P/B ratio

6.64

02 · Per share & returns

EPS (TTM)

₹48.78

Book value

₹261

ROE

19.57%

ROA

9.62%

Dividend yield

0.18%

Beta

—

03 · Financials (TTM)

By the numbers

Revenue

₹9204 Cr

+16.70% YoY

EBITDA

₹1789 Cr

Net profit

₹924 Cr

+28.80% YoY

Profit margin

10.04%

Operating margin

15.35%

Total debt

₹1521 Cr

Total cash

₹148 Cr

Debt / equity

0.31x

Current ratio

1.43x

Payout ratio

6.15%

04 · Analyst view

Target price

₹1,892

Upside

+9.11%

Consensus

NONE

Analysts

05 · Shareholding pattern

Who owns EMCURE?

Promoters
77.87%
Founders & promoter group
Institutions
5.38%
FII + DII
Public
16.75%
Retail & non-institutional

As of 31 Mar 2026 · Source: NSE corporate filings

06 · Registration & listing

On the record

Symbol: EMCURE
Exchange: NSE · BSE
CIN: —
ISIN: INE168P01015
BSE code: 544210
Sector: Healthcare
Industry: Healthcare
Face value: ₹10
Listing date: 09 Jul 2024
Employees: —
Headquarters: Pune, India
Website: www.emcure.com

07 · About

What is Emcure Pharmaceuticals Limited?

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular. It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names. Emcure Pharmaceuticals Limited has a strategic partnership with Novo Nordisk India Pvt Ltd. for the development and commercialization of Poviztra, a semaglutide injection for weight loss. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.

08 · Common questions

Frequently asked

What is the CIN of Emcure Pharmaceuticals Limited?+

The Corporate Identity Number for Emcure Pharmaceuticals Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Emcure Pharmaceuticals Limited?+

Promoter holding in EMCURE is approximately 77.87%, as disclosed in the latest published shareholding pattern.

What is the market capitalisation of Emcure Pharmaceuticals Limited?+

Emcure Pharmaceuticals Limited (EMCURE) has a market capitalisation of approximately ₹32885 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent